1 |
Segura-aguilar J, Mannervik B. A Preclinical Model for Parkinson’s Disease Based on Transcriptional Gene Activation via KEAP1/NRF2 to Develop New Antioxidant Therapies. Antioxidants 2023;12:673. [DOI: 10.3390/antiox12030673] [Reference Citation Analysis]
|
2 |
Kim KW, Lee YS, Yoon D, Kim GS, Lee DY. The ethanolic extract of Curcuma longa grown in Korea exhibits anti-neuroinflammatory effects by activating of nuclear transcription factor erythroid-2-related factor 2/heme oxygenase-1 signaling pathway. BMC Complement Med Ther 2022;22:343. [PMID: 36585647 DOI: 10.1186/s12906-022-03825-5] [Reference Citation Analysis]
|
3 |
Abu-Elfotuh K, Hamdan AME, Mohammed AA, Atwa AM, Kozman MR, Ibrahim AM, Motawea SM, Selim HMRM, Tohamy STK, Nour El-Din M, Zaghlool SS, Gowifel AMH, Awny MM. Neuroprotective Effects of Some Nutraceuticals against Manganese-Induced Parkinson's Disease in Rats: Possible Modulatory Effects on TLR4/NLRP3/NF-κB, GSK-3β, Nrf2/HO-1, and Apoptotic Pathways. Pharmaceuticals (Basel) 2022;15. [PMID: 36559006 DOI: 10.3390/ph15121554] [Reference Citation Analysis]
|
4 |
Fu R, Tsai C, Liu S, Chiu S, Chen Y, Chiang Y, Kuo Y, Shyu W, Lin S. Neuroprotective Capability of Narcissoside in 6-OHDA-Exposed Parkinson’s Disease Models through Enhancing the MiR200a/Nrf-2/GSH Axis and Mediating MAPK/Akt Associated Signaling Pathway. Antioxidants 2022;11:2089. [DOI: 10.3390/antiox11112089] [Reference Citation Analysis]
|